TrialArthritis research & therapy2016

Changes in plasma CXCL4 levels are associated with improvements in lung function in patients receiving immunosuppressive therapy for systemic sclerosis-related interstitial lung disease.

Elizabeth R Volkmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.